BREANNA MEADOWS: Open Payments
NPI 1164171831 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 30 payments from 13 companies in 2025. Trend: 2023 $91 · 2024 $221 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $141 |
| Corcept Therapeutics | 6 | $101 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Paratek Pharmaceuticals, Inc. | 3 | $46 |
| Amgen Inc. | 2 | $38 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: VRAYLAR, Korlym, AIRSUPRA, NUZYRA, Veozah, OTEZLA, REPATHA, WATCHMAN Access System.
Industry payments across TN — which companies pay providers there.
